Roché H - Search Results

1

[Prediction of carboplatin clearance from morphological and biological patient characteristics].

Chatelut E, Dezeuze A, Lavit M, Chevreau C, Pujol A, Boneu A, Roché H, Houin G, Bugat R, Canal P. Chatelut E, et al. Among authors: roche h. Bull Cancer. 1995 Nov;82(11):946-53. Bull Cancer. 1995. PMID: 8535021 French.

2

Prediction of carboplatin clearance from standard morphological and biological patient characteristics.

Chatelut E, Canal P, Brunner V, Chevreau C, Pujol A, Boneu A, Roché H, Houin G, Bugat R. Chatelut E, et al. Among authors: roche h. J Natl Cancer Inst. 1995 Apr 19;87(8):573-80. doi: 10.1093/jnci/87.8.573. J Natl Cancer Inst. 1995. PMID: 7752255

3

[Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers].

de Forni M, Gualano V, Canal P, Martel P, Izar-Soum F, Chevreau C, Soulié P, Roché H, Bugat R. de Forni M, et al. Among authors: roche h. Bull Cancer. 1993 May;80(5):408-17. Bull Cancer. 1993. PMID: 8173194 Clinical Trial. French.

4

Population pharmacokinetics of carboplatin in children.

Chatelut E, Boddy AV, Peng B, Rubie H, Lavit M, Dezeuze A, Pearson AD, Roché H, Robert A, Newell DR, Canal P. Chatelut E, et al. Among authors: roche h. Clin Pharmacol Ther. 1996 Apr;59(4):436-43. doi: 10.1016/S0009-9236(96)90113-7. Clin Pharmacol Ther. 1996. PMID: 8612389 Clinical Trial.

5

Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.

Chatelut E, Chevreau C, Blancy E, Lequellec A, Canal P, Roche H, Houin G, Bugat R. Chatelut E, et al. Among authors: roche h. Cancer Chemother Pharmacol. 1990;26(5):365-8. doi: 10.1007/BF02897295. Cancer Chemother Pharmacol. 1990. PMID: 2170043

6

[A phase II study with mitoxantrone-vinorelbine association in the treatment of advanced breast cancer in elderly women].

Gladieff L, Houyau P, Mihura J, Martinez M, Caunes N, Chevreau C, Bugat R, Roché H. Gladieff L, et al. Among authors: roche h. Bull Cancer. 1996 Sep;83(9):703-6. Bull Cancer. 1996. PMID: 8952644 Clinical Trial. French.

7

Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in children.

Chatelut E, Roche H, Plusquellec Y, Peyrille F, De Biasi J, Pujol A, Canal P, Houin G. Chatelut E, et al. Among authors: roche h. J Pharm Sci. 1991 Aug;80(8):730-4. doi: 10.1002/jps.2600800804. J Pharm Sci. 1991. PMID: 1791530

8

Phase I/II pharmacokinetic study of mitoxantrone by continuous venous infusion in patients with solid tumours and lymphoproliferative diseases.

de Forni M, Lachau S, Huguet F, Canal P, Laurent G, Chevreau C, Roche H, Bugat R. de Forni M, et al. Among authors: roche h. Eur J Cancer. 1991;27(6):735-9. doi: 10.1016/0277-5379(91)90177-f. Eur J Cancer. 1991. PMID: 1829914

9

Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.

Chatelut E, de Forni M, Canal P, Chevreau C, Roche H, Plusquellec Y, Johnson NP, Houin G, Bugat R. Chatelut E, et al. Among authors: roche h. Ann Oncol. 1991 Mar;2(3):217-21. doi: 10.1093/oxfordjournals.annonc.a057910. Ann Oncol. 1991. PMID: 2043492 Free article. Clinical Trial.

10

Chronopharmacokinetics of doxorubicin in patients with breast cancer.

Canal P, Sqall A, de Forni M, Chevreau C, Pujol A, Bugat R, Roche H, Oustrin J, Houin G. Canal P, et al. Among authors: roche h. Eur J Clin Pharmacol. 1991;40(3):287-91. doi: 10.1007/BF00315211. Eur J Clin Pharmacol. 1991. PMID: 2060566 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

597 results

Search Page

Filters